Literature DB >> 34114194

Promoting exercise for patients with multiple myeloma: attitudes and practices of clinical haematologists.

Jennifer L Nicol1, Michelle M Hill2,3, Nicola W Burton4, Tina L Skinner5.   

Abstract

PURPOSE: To explore the attitudes and practices of clinical haematologists towards promoting physical activity (PA) and exercise for patients with multiple myeloma (MM).
METHODS: Using a quantitative cross-sectional survey, clinical haematologists reported on the perceived benefits and acceptability of PA and exercise and frequency, confidence and barriers to providing exercise advice.
RESULTS: Clinical haematologists (n=34; 68% response rate), who cumulatively treated ~340 patients with MM each week, completed the survey. Almost all (97%) agreed that PA was important, with benefits for quality of life, activities of daily living, mental health and fatigue. Whilst 88% discussed PA at least occasionally with their patients, approximately two-thirds were not confident advising specific exercises (68%) or identifying PA resources (62%). Despite this, 44% never referred patients to exercise professionals, with 18% only doing so if the patient asked. Over half did not recommend exercise when patients had spine fractures or were physically unwell. No differences were observed in individual factors (age, gender, practice type and own PA participation) and promotion of PA.
CONCLUSIONS: Clinical haematologists perceive PA as important, but lack confidence on what exercise/s to recommend and if exercise is appropriate for specific disease complications. They tend to not refer patients to exercise professionals. IMPLICATIONS FOR CANCER SURVIVORS: Patients with MM often suffer from symptoms and toxicities that may be alleviated through PA. However, PA participation rates are low. Support for clinical haematologists for when and how to discuss exercise, and clearer referral pathways to exercise professionals may improve PA uptake and hence ensure access to optimal care, thereby improving patient outcomes.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Physical activity; Physicians; Supportive care; Survey; Symptoms

Mesh:

Year:  2021        PMID: 34114194     DOI: 10.1007/s11764-021-01062-2

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  18 in total

1.  Effects of an oncologist's recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial.

Authors:  Lee W Jones; Kerry S Courneya; Adrian S Fairey; John R Mackey
Journal:  Ann Behav Med       Date:  2004-10

2.  Steroid-Associated Side Effects: A Symptom Management Update on Multiple Myeloma Treatment
.

Authors:  Tracy King; Beth Faiman
Journal:  Clin J Oncol Nurs       Date:  2017-04-01       Impact factor: 1.027

3.  Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma.

Authors:  D M Greenfield; E Boland; Y Ezaydi; R J M Ross; S H Ahmedzai; J A Snowden
Journal:  Bone Marrow Transplant       Date:  2014-04-07       Impact factor: 5.483

Review 4.  Multiple myeloma.

Authors:  Shaji K Kumar; Vincent Rajkumar; Robert A Kyle; Mark van Duin; Pieter Sonneveld; María-Victoria Mateos; Francesca Gay; Kenneth C Anderson
Journal:  Nat Rev Dis Primers       Date:  2017-07-20       Impact factor: 52.329

Review 5.  Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis.

Authors:  Christina Ramsenthaler; Pauline Kane; Wei Gao; Richard J Siegert; Polly M Edmonds; Stephen A Schey; Irene J Higginson
Journal:  Eur J Haematol       Date:  2016-09-06       Impact factor: 2.997

Review 6.  Pathogenesis of myeloma bone disease.

Authors:  G D Roodman
Journal:  Leukemia       Date:  2008-11-27       Impact factor: 11.528

7.  Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable.

Authors:  Kristin L Campbell; Kerri M Winters-Stone; Joachim Wiskemann; Anne M May; Anna L Schwartz; Kerry S Courneya; David S Zucker; Charles E Matthews; Jennifer A Ligibel; Lynn H Gerber; G Stephen Morris; Alpa V Patel; Trisha F Hue; Frank M Perna; Kathryn H Schmitz
Journal:  Med Sci Sports Exerc       Date:  2019-11       Impact factor: 5.411

8.  Recall of physical activity advice was associated with higher levels of physical activity in colorectal cancer patients.

Authors:  A Fisher; K Williams; R Beeken; J Wardle
Journal:  BMJ Open       Date:  2015-04-28       Impact factor: 2.692

9.  Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016.

Authors:  Andrew J Cowan; Christine Allen; Aleksandra Barac; Huda Basaleem; Isabela Bensenor; Maria Paula Curado; Kyle Foreman; Rahul Gupta; James Harvey; H Dean Hosgood; Mihajlo Jakovljevic; Yousef Khader; Shai Linn; Deepesh Lad; Lorenzo Mantovani; Vuong Minh Nong; Ali Mokdad; Mohsen Naghavi; Maarten Postma; Gholamreza Roshandel; Katya Shackelford; Mekonnen Sisay; Cuong Tat Nguyen; Tung Thanh Tran; Bach Tran Xuan; Kingsley Nnanna Ukwaja; Stein Emil Vollset; Elisabete Weiderpass; Edward N Libby; Christina Fitzmaurice
Journal:  JAMA Oncol       Date:  2018-09-01       Impact factor: 31.777

10.  The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study.

Authors:  Christina Ramsenthaler; Thomas R Osborne; Wei Gao; Richard J Siegert; Polly M Edmonds; Stephen A Schey; Irene J Higginson
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

View more
  1 in total

1.  An Individualized Exercise Intervention for People with Multiple Myeloma-Study Protocol of a Randomized Waitlist-Controlled Trial.

Authors:  Jennifer L Nicol; Carmel Woodrow; Brent J Cunningham; Peter Mollee; Nicholas Weber; Michelle D Smith; Andrew J Nicol; Louisa G Gordon; Michelle M Hill; Tina L Skinner
Journal:  Curr Oncol       Date:  2022-02-07       Impact factor: 3.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.